New guidance on prescribing opioids unveiled Thursday by the Centers for Disease Control and Prevention avoids the strict limits found in a 2016 version that accelerated a nationwide drop in pain pill prescriptions but led to backlash from chronic pain patients.
The 229-page document advises doctors to limit new opioid prescriptions and discuss alternative therapies with patients. But the new guidance largely avoids figures on dosage and length of prescription and warns against abruptly or rapidly discontinuing pain pills for some chronic pain patients.
"We've built in flexibility so that there's not a one-size-fits-all approach," said Christopher Jones, acting director of the CDC's National Center for Injury Prevention and Control.
Advocate Health, the third largest non-profit health system in the country, has announced it will cancel...
or the first time in decades, public health data shows a sudden and hopeful drop in...
